Lifastuzumab vedotin, CAS [[1401812-88-1]]

Product Overview

• Article Name: Lifastuzumab vedotin, CAS [[1401812-88-1]]
• Biozol Catalog Number: TGM-T9901A-025
• Supplier Catalog Number: T9901A-025
• Alternative Catalog Number: TGM-T9901A-025-1MG,TGM-T9901A-025-5MG,TGM-T9901A-025-10MG
• Manufacturer: TargetMol
• Category: Biochemikalien
• Alternative Names: DNIB0600A

Product Description

Lifastuzumab vedotin (DNIB0600A), an antibody-drug conjugate (ADC), consists of a humanized IgG1 monoclonal antibody targeting NaPi2b (MNIB2126A) linked to the potent antimitotic agent monomethyl auristatin E (MMAE), which disrupts cell division by inhibiting tubulin polymerization. This compound shows promise for research in non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) [1].

Product Properties

• CAS Number: [1401812-88-1]
• Target: Antibody-Drug Conjugates (ADCs)|||Others